Organizations aim to get their assets discovered, approved, commercialized, and in the hands of patients as fast as safely possible -- but there’s one type of delay that can upend timelines in unexpected ways: procurement.
Present in the end-to-end journey of drug development, procurement complexities are an inherent – but not always well-predicted or understood – concern from bench to clinical to commercial stages. Without a cohesive procurement strategy, critical tasks are often prone to disorganization, stakeholder frustrations, and costly oversights.
But what if there were a way to preempt those pains with an AI-powered approach? In this webinar, join experts as they walk through emerging opportunities for biopharma leaders to operationalize and overcome procurement challenges through new trends in so-called “procurement orchestration.” You’ll learn:
Offered Free by: BioPharma Dive's studioID and ORO Labs
See All Resources from: BioPharma Dive's studioID and ORO Labs
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.